Instructions Herbion syrup Icelandic moss syrup 6 mg/ml bottle 150 ml
Composition
active ingredient: 1 ml of syrup contains 6 mg of thick extract of Icelandic moss (Cetraria islandica (L.) Acharius sl, thallus) (16-18:1); extractant: purified water;
Excipients: sorbitol solution, non-crystallizing (E 420); xanthan gum; sodium benzoate (E 211); citric acid, monohydrate; lemon flavoring (contains ethanol); purified water.
Dosage form
Syrup.
Main physical and chemical properties: slightly opalescent liquid from yellow-brown to brown in color with a specific odor and taste. A slight precipitate characteristic of natural substances may be observed.
Pharmacotherapeutic group
Agents that suppress the cough reflex, except combinations with expectorants.
ATX code R05D.
Pharmacological properties
Pharmacodynamics.
Herbion Icelandic moss syrup contains a thick extract of Icelandic moss, which has antitussive, immunostimulating, antibacterial and anti-inflammatory effects. The main components of Icelandic moss extract are mucus in the form of water-soluble polysaccharides, mainly lichenin and isolichenin, as well as bitter lichen acids. Polysaccharides have an enveloping effect on the mucous membranes of the upper respiratory tract, forming a protective layer that has a soothing effect on the surface of the mucous membranes, thereby reducing the cough reflex caused by external irritants and softening dry and irritating cough. Mucus also combines with water on the surface of the mucous membrane and thus has a local enveloping effect on irritated and dry mucous membranes of the mouth and throat.
Pharmacokinetics.
There are no data on the pharmacokinetic properties of thick Icelandic moss extract.
Indication
- Dry, irritating cough and hoarseness;
- dryness of mucous membranes in dry air of living rooms or in insufficiently humidified office spaces during the heating period, as well as with limited nasal breathing or during sports activities;
- heavy load on the vocal cords.
Contraindication
Hypersensitivity to the active substance or any excipients.
Interaction with other medicinal products and other types of interactions
There are no reports of the effect of Herbion Icelandic moss syrup on the effects of other drugs. No interaction studies have been conducted.
Application features
If you experience shortness of breath, fever, purulent and bloody sputum, hoarseness, or bloody nasal discharge, you should consult a doctor.
If the condition does not improve after 4-5 days after starting treatment, you should consult a doctor.
Herbion Icelandic moss syrup contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
This medicine contains a small amount of ethanol (alcohol), less than 100 mg/dose.
Use during pregnancy or breastfeeding
Since clinical data on the use of Iceland moss extract during pregnancy and lactation are limited, the syrup is not recommended for use in pregnant and breastfeeding women.
There are no data on the effect of this drug on fertility.
Ability to influence reaction speed when driving vehicles or other mechanisms
There is no data on the negative impact of the drug Herbion Icelandic moss syrup on the reaction speed when driving vehicles or working with other mechanisms.
Method of administration and doses
Shake the bottle before use. Administer to adults and children orally, using a measuring spoon.
Adults and children over 16 years of age: 15 ml of syrup 4 times a day (corresponding to 360 mg of thick Icelandic moss extract per day).
Children aged 10 to 16 years: 10 ml of syrup 4 times a day (corresponding to 240 mg of thick Icelandic moss extract per day).
Children aged 4 to 10 years: 5 ml of syrup 4 times a day (corresponding to 120 mg of thick Icelandic moss extract per day).
Children aged 1 to 4 years: 2.5 ml of syrup 4 times a day (corresponding to 60 mg of thick Icelandic moss extract per day).
It is recommended to drink Herbion Icelandic moss syrup with plenty of tea or another warm drink, but not earlier than 20 minutes after taking the drug, as the drug is quickly removed from the mucous membrane of the mouth and throat.
The duration of treatment depends on the course and severity of the disease and is determined by the doctor individually. After the disappearance of clinical symptoms of the disease, it is recommended to take the drug for several more days.
Children
The drug is used in children aged 1 year and older.
Overdose
Do not take doses exceeding the recommended ones. No cases of overdose have been observed.
Adverse reactions
In rare cases, allergic reactions may occur.
If any undesirable side effects occur, treatment should be discontinued and a doctor should be consulted.
Expiration date
The medicine should be used within 3 months after first opening the bottle.
Storage conditions
Keep out of reach of children.
Do not refrigerate.
Packaging
150 ml of syrup in a bottle, 1 bottle together with a measuring spoon in a cardboard box.
Vacation category
Without a prescription.
Producer
KRKA, dd, Novo mesto, Slovenia.
Location of the manufacturer and its business address
Smarjeska cesta 6, 8501 Novo mesto, Slovenia.
